Skip to content

Clinical trials

Obesity trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Country / region: Brazil Clear all

281 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20044
20054
20065
200714
20084
200912
201011
20119
20128
201312
201414
201516
201616
201724
201812
201912
20204
202112
202214
202317
202410
202517
202627

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed155
Unknown status56
Recruiting29
Active, not recruiting16
Not yet recruiting9
Withdrawn7
Terminated6
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo36
Eli Lilly and Company22
Federal University of São Paulo16
Rio de Janeiro State University15
University of Sao Paulo General Hospital14
Hospital de Clinicas de Porto Alegre12
Novo Nordisk A/S11
Federal University of Minas Gerais9
University of Campinas, Brazil9
Kaiser Clinic and Hospital7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity281
Overweight81
Diabetes Mellitus, Type 223
Diabetes Mellitus13
Metabolic Syndrome13
Obesity, Morbid12
Sleep Apnea, Obstructive12
Weight Loss12
Inflammation9
Insulin Resistance9

Trials

Showing 26 to 50 of 281. Each trial links to its page on Pharma Observatory.

181 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.